“Long-term Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s87. doi:10.25251/skin.4.supp.87.